Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene

Respirology

Volumn 15, Issue 4, 2010, Pages 700-705

  Fong, Yao ^a   Lin, Yue Shan ^b   Liou, Chiou Ping ^c   Li, Chien Fen ^c   Tzeng, Ching Cherng ^c  

^a Department of Surgery   (Australia)

^b Department of Obstetrics and Gynecology ^*  (Australia)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Comparative genomic hybridization; Epidermal growth factor receptor; Lung adenocarcinoma; Mutation; Polymerase chain reaction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ADENOCARCINOMA; GENETICS; LUNG TUMOR; MIDDLE AGED; MUTATION; NON SMALL CELL LUNG CANCER; RETROSPECTIVE STUDY; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 77951720965     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01746.x     Document Type: Article

References (36)

1. Yoshimi I, Ohshima A, Ajiki W et al. A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn. J. Clin. Oncol. 2003 33 : 98 104.
2. Chen KY, Chang CH, Yu CJ et al. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer 2005 103 : 2566 2574.
3. Devesa SS, Bray F, Vizcaino AP et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer 2005 117 : 294 299.
4. Pirozynski M. 100 years of lung cancer. Respir. Med. 2006 100 : 2073 2084.
5. Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004 350 : 2129 2139.
6. Paez JG, Jänne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004 304 : 1497 1500.
7. Huang SF, Liu HP, Li LH et al. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin. Cancer Res. 2004 10 : 8195 8203.
8. Kosaka T, Yatabe Y, Endoh H et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004 64 : 8919 8923.
9. Shigematsu H, Lin L, Takahashi T et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J. Natl. Cancer Inst. 2005 97 : 339 346. (Pubitemid 40425952)
10. Pan Q, Pao W, Ladanyi M. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J. Mol. Diagn. 2005 7 : 396 403.
11. Tam IY, Chung LP, Suen WS et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin. Cancer Res. 2006 12 : 1647 1653.
12. Greulich H, Chen TH, Feng W et al. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med. 2005 2 : e313.
13. Sasaki H, Endo K, Takada M et al. EGFR exon 20 insertion mutation in Japanese lung cancer. Lung Cancer 2007 58 : 324 328. (Pubitemid 350051507)
14. Wu JY, Wu SG, Yang CH et al. Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response. Clin. Cancer Res. 2008 14 : 4877 4882.
15. Jiang J, Greulich H, Jänne PA et al. Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression. Cancer Res. 2005 65 : 8968 8974.
16. Asano H, Toyooka S, Tokumo M et al. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin. Cancer Res. 2006 12 : 43 8.
17. Ohnishi H, Ohtsuka K, Ooide A et al. A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non-small-cell lung carcinoma. Diagn. Mol. Pathol. 2006 15 : 101 108. (Pubitemid 44350487)
18. Kallioniemi A, Kallioniemi OP, Sudar D et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992 258 : 818 821.
19. Shibata T, Uryu S, Kokubu A et al. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin. Cancer Res. 2005 11 : 6177 6185.
20. Reinmuth N, Jauch A, Xu EC et al. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Lung Cancer 2008 62 : 193 201.
21. Chitale D, Gong Y, Taylor BS et al. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 2009 28 : 2773 2783.
22. Nakanishi H, Matsumoto S, Iwakawa R et al. Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas. Cancer Res. 2009 69 : 1615 1623.
23. Lin YS, Eng HL, Jan YJ et al. Molecular cytogenetics of ovarian granulosa cell tumors by comparative genomic hybridization. Gynecol. Oncol. 2005 97 : 68 73.
24. Pao W, Miller V, Zakowski M et al. EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl. Acad. Sci. USA 2004 101 : 13306 13311.
25. Kirchhoff M, Gerdes T, Rose H et al. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 1998 3 : 163 173.
26. Sasaki H, Endo K, Takada M et al. L858R EGFR mutation status correlated with clinicopathological features of Japanese lung cancer. Lung Cancer 2006 54 : 103 108.
27. Kim YT, Kim TY, Lee DS et al. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Lung Cancer 2008 59 : 111 118.
28. Tsao AS, Tang XM, Sabloff B et al. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer. J. Thorac. Oncol. 2006 1 : 231 239.
29. Jang TW, Oak CH, Chang HK et al. EGFR and KRAS mutations in patients with adenocarcinoma of the lung. Korean J. Intern. Med. 2009 24 : 48 54.
30. Petersen I, Bujard M, Petersen S et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 1997 57 : 2331 2335.
31. Pei J, Balsara BR, Li W et al. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer 2001 31 : 282 287.
32. Goeze A, Schluns K, Wolf G et al. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J. Pathol. 2002 196 : 8 16.
33. Wong MP, Fung LF, Wang E et al. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers. Cancer 2003 97 : 1263 1270.
34. Sy SM, Wong N, Lee TW et al. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur. J. Cancer 2004 40 : 1082 1094.
35. Weir BA, Woo MS, Getz G et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007 450 : 893 898.
36. Shen H, Zhu Y, Wu YJ et al. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization. Cancer Genet. Cytogenet. 2008 181 : 100 107.